 Jeremy Dubin
Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 37 | 2026 | 370 | 10.180 |
Why?
| | Arthroplasty, Replacement, Hip | 33 | 2025 | 182 | 9.850 |
Why?
| | Arthroplasty, Replacement | 6 | 2025 | 47 | 3.630 |
Why?
| | Prosthesis-Related Infections | 15 | 2024 | 99 | 3.590 |
Why?
| | Social Determinants of Health | 8 | 2025 | 301 | 3.550 |
Why?
| | Postoperative Complications | 26 | 2026 | 2919 | 2.630 |
Why?
| | Reoperation | 18 | 2025 | 630 | 2.550 |
Why?
| | Knee Prosthesis | 5 | 2024 | 28 | 1.870 |
Why?
| | Arthroplasty | 5 | 2023 | 59 | 1.840 |
Why?
| | Search Engine | 3 | 2024 | 12 | 1.830 |
Why?
| | Hip Prosthesis | 8 | 2025 | 42 | 1.730 |
Why?
| | Femur Head Necrosis | 5 | 2025 | 15 | 1.710 |
Why?
| | Orthopedics | 4 | 2024 | 169 | 1.670 |
Why?
| | Osteonecrosis | 2 | 2025 | 23 | 1.650 |
Why?
| | Arthritis, Infectious | 6 | 2024 | 72 | 1.620 |
Why?
| | Surgical Wound Infection | 6 | 2024 | 316 | 1.530 |
Why?
| | Venous Thrombosis | 4 | 2024 | 194 | 1.530 |
Why?
| | Knee Joint | 6 | 2025 | 426 | 1.490 |
Why?
| | Artificial Intelligence | 5 | 2024 | 365 | 1.460 |
Why?
| | Internet | 2 | 2024 | 699 | 1.150 |
Why?
| | Arthroplasty, Replacement, Shoulder | 6 | 2024 | 40 | 1.140 |
Why?
| | Bone Nails | 2 | 2025 | 62 | 1.080 |
Why?
| | Arthroscopy | 3 | 2024 | 267 | 1.060 |
Why?
| | Prosthesis Failure | 7 | 2025 | 127 | 1.050 |
Why?
| | Fracture Fixation, Internal | 6 | 2024 | 207 | 1.030 |
Why?
| | Conflict of Interest | 2 | 2024 | 52 | 1.020 |
Why?
| | Humans | 95 | 2026 | 144759 | 1.010 |
Why?
| | Retrospective Studies | 41 | 2026 | 17066 | 1.000 |
Why?
| | Shoulder Joint | 3 | 2023 | 198 | 0.990 |
Why?
| | Adrenal Cortex Hormones | 5 | 2024 | 478 | 0.940 |
Why?
| | Aged | 40 | 2026 | 25913 | 0.930 |
Why?
| | Healthcare Disparities | 4 | 2025 | 727 | 0.930 |
Why?
| | Femoral Neck Fractures | 2 | 2024 | 21 | 0.920 |
Why?
| | Propensity Score | 2 | 2024 | 367 | 0.900 |
Why?
| | Bone Lengthening | 1 | 2025 | 8 | 0.890 |
Why?
| | Aspirin | 3 | 2025 | 399 | 0.840 |
Why?
| | Weight Loss | 3 | 2024 | 836 | 0.840 |
Why?
| | Polyethylene | 1 | 2024 | 17 | 0.830 |
Why?
| | Pulmonary Embolism | 2 | 2024 | 244 | 0.830 |
Why?
| | Orthopedic Procedures | 2 | 2023 | 243 | 0.820 |
Why?
| | Femoral Fractures | 2 | 2024 | 82 | 0.820 |
Why?
| | Tennis Elbow | 1 | 2023 | 3 | 0.810 |
Why?
| | Femur | 2 | 2025 | 250 | 0.810 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2024 | 80 | 0.790 |
Why?
| | Range of Motion, Articular | 3 | 2024 | 421 | 0.780 |
Why?
| | Bibliometrics | 1 | 2023 | 63 | 0.780 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 88 | 0.780 |
Why?
| | Enoxaparin | 1 | 2024 | 67 | 0.780 |
Why?
| | Wound Healing | 2 | 2022 | 351 | 0.770 |
Why?
| | Length of Stay | 4 | 2025 | 1337 | 0.760 |
Why?
| | Medicare | 4 | 2024 | 886 | 0.760 |
Why?
| | Income | 1 | 2024 | 202 | 0.760 |
Why?
| | Wound Closure Techniques | 1 | 2022 | 13 | 0.760 |
Why?
| | Warfarin | 1 | 2024 | 170 | 0.750 |
Why?
| | Surgical Wound | 1 | 2022 | 27 | 0.740 |
Why?
| | Joint Diseases | 1 | 2023 | 62 | 0.740 |
Why?
| | Hip Dislocation | 1 | 2023 | 53 | 0.740 |
Why?
| | Prosthesis Design | 5 | 2025 | 357 | 0.740 |
Why?
| | Intraoperative Care | 1 | 2022 | 62 | 0.730 |
Why?
| | Hemiarthroplasty | 1 | 2022 | 10 | 0.720 |
Why?
| | Anticoagulants | 2 | 2025 | 722 | 0.720 |
Why?
| | Middle Aged | 33 | 2026 | 35875 | 0.690 |
Why?
| | Periprosthetic Fractures | 4 | 2024 | 6 | 0.680 |
Why?
| | Risk Factors | 18 | 2025 | 10779 | 0.660 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2021 | 60 | 0.640 |
Why?
| | Medicaid | 1 | 2024 | 461 | 0.620 |
Why?
| | Hip Fractures | 1 | 2021 | 84 | 0.620 |
Why?
| | Treatment Outcome | 18 | 2025 | 11679 | 0.610 |
Why?
| | Bone Cements | 3 | 2024 | 39 | 0.610 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 300 | 0.610 |
Why?
| | Incidence | 10 | 2026 | 2879 | 0.600 |
Why?
| | Tenocytes | 1 | 2018 | 5 | 0.570 |
Why?
| | Male | 42 | 2026 | 72315 | 0.570 |
Why?
| | Machine Learning | 1 | 2024 | 585 | 0.550 |
Why?
| | Female | 39 | 2026 | 78271 | 0.520 |
Why?
| | Tendons | 1 | 2018 | 129 | 0.510 |
Why?
| | Robotic Surgical Procedures | 3 | 2024 | 182 | 0.500 |
Why?
| | United States | 12 | 2025 | 15966 | 0.480 |
Why?
| | Stroke | 2 | 2023 | 1256 | 0.480 |
Why?
| | Decompression, Surgical | 4 | 2023 | 116 | 0.470 |
Why?
| | Databases, Factual | 4 | 2024 | 1486 | 0.440 |
Why?
| | Patella | 2 | 2025 | 28 | 0.430 |
Why?
| | Aged, 80 and over | 9 | 2024 | 8265 | 0.420 |
Why?
| | Osteogenesis, Distraction | 2 | 2025 | 25 | 0.420 |
Why?
| | Maryland | 2 | 2024 | 66 | 0.410 |
Why?
| | Patellar Ligament | 2 | 2024 | 26 | 0.410 |
Why?
| | Tendon Injuries | 2 | 2025 | 73 | 0.410 |
Why?
| | Shoulder | 2 | 2023 | 105 | 0.380 |
Why?
| | Osteoporosis | 2 | 2026 | 236 | 0.360 |
Why?
| | Comorbidity | 4 | 2024 | 1658 | 0.360 |
Why?
| | MicroRNAs | 1 | 2018 | 701 | 0.350 |
Why?
| | Socioeconomic Factors | 3 | 2025 | 1326 | 0.350 |
Why?
| | Insurance, Health | 2 | 2024 | 302 | 0.340 |
Why?
| | Time Factors | 5 | 2024 | 7173 | 0.330 |
Why?
| | Osteoarthritis | 2 | 2023 | 196 | 0.320 |
Why?
| | Weight-Bearing | 2 | 2022 | 181 | 0.320 |
Why?
| | Venous Thromboembolism | 2 | 2025 | 324 | 0.310 |
Why?
| | Acetabulum | 3 | 2024 | 111 | 0.290 |
Why?
| | Patient Reported Outcome Measures | 5 | 2024 | 488 | 0.270 |
Why?
| | Adult | 18 | 2025 | 40449 | 0.270 |
Why?
| | Injections, Intra-Articular | 2 | 2024 | 58 | 0.260 |
Why?
| | Orthopedic Surgeons | 2 | 2024 | 30 | 0.250 |
Why?
| | Motivation | 2 | 2022 | 610 | 0.250 |
Why?
| | Cadaver | 2 | 2024 | 304 | 0.240 |
Why?
| | Joint Instability | 2 | 2025 | 182 | 0.230 |
Why?
| | Leg Length Inequality | 1 | 2025 | 6 | 0.220 |
Why?
| | Social Class | 2 | 2024 | 268 | 0.220 |
Why?
| | Bone Density Conservation Agents | 1 | 2026 | 81 | 0.220 |
Why?
| | Foot Injuries | 1 | 2025 | 23 | 0.220 |
Why?
| | Soft Tissue Injuries | 1 | 2025 | 34 | 0.220 |
Why?
| | Ceramics | 1 | 2025 | 22 | 0.220 |
Why?
| | Body Mass Index | 2 | 2024 | 2438 | 0.220 |
Why?
| | Publication Bias | 1 | 2024 | 17 | 0.220 |
Why?
| | Drainage | 2 | 2022 | 185 | 0.220 |
Why?
| | Chromium | 1 | 2024 | 17 | 0.210 |
Why?
| | Young Adult | 7 | 2025 | 14105 | 0.210 |
Why?
| | Managed Care Programs | 1 | 2025 | 138 | 0.210 |
Why?
| | Ankle Injuries | 1 | 2025 | 65 | 0.210 |
Why?
| | Cobalt | 1 | 2024 | 53 | 0.210 |
Why?
| | Capitate Bone | 1 | 2024 | 3 | 0.210 |
Why?
| | Research Support as Topic | 1 | 2024 | 80 | 0.210 |
Why?
| | Lunate Bone | 1 | 2024 | 10 | 0.210 |
Why?
| | Quadriceps Muscle | 1 | 2025 | 118 | 0.200 |
Why?
| | Shoulder Fractures | 1 | 2023 | 14 | 0.200 |
Why?
| | Fractures, Avulsion | 1 | 2023 | 2 | 0.200 |
Why?
| | Ligaments, Articular | 1 | 2024 | 54 | 0.200 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2023 | 30 | 0.200 |
Why?
| | Nerve Sheath Neoplasms | 1 | 2023 | 13 | 0.200 |
Why?
| | Trigger Finger Disorder | 1 | 2023 | 8 | 0.200 |
Why?
| | Osteoarthritis, Hip | 1 | 2023 | 45 | 0.200 |
Why?
| | Elbow Joint | 1 | 2024 | 74 | 0.200 |
Why?
| | Patient Care Bundles | 1 | 2023 | 28 | 0.200 |
Why?
| | Humeral Head | 1 | 2023 | 20 | 0.200 |
Why?
| | Peripheral Nervous System Neoplasms | 1 | 2023 | 19 | 0.200 |
Why?
| | Groin | 1 | 2023 | 13 | 0.190 |
Why?
| | Disclosure | 1 | 2023 | 85 | 0.190 |
Why?
| | Skilled Nursing Facilities | 1 | 2025 | 151 | 0.190 |
Why?
| | Information Seeking Behavior | 1 | 2023 | 38 | 0.190 |
Why?
| | Hamartoma | 1 | 2023 | 29 | 0.190 |
Why?
| | Wearable Electronic Devices | 1 | 2024 | 63 | 0.190 |
Why?
| | Consumer Health Information | 1 | 2023 | 49 | 0.190 |
Why?
| | Forecasting | 2 | 2024 | 391 | 0.190 |
Why?
| | Bone Transplantation | 1 | 2023 | 86 | 0.190 |
Why?
| | Smartphone | 1 | 2024 | 102 | 0.190 |
Why?
| | Patient Satisfaction | 2 | 2024 | 704 | 0.190 |
Why?
| | Pain | 3 | 2023 | 779 | 0.190 |
Why?
| | Tibial Fractures | 1 | 2023 | 72 | 0.190 |
Why?
| | Tourniquets | 1 | 2022 | 34 | 0.190 |
Why?
| | Tranexamic Acid | 1 | 2022 | 53 | 0.180 |
Why?
| | Soft Tissue Neoplasms | 1 | 2023 | 127 | 0.180 |
Why?
| | Adolescent | 7 | 2025 | 22428 | 0.180 |
Why?
| | Rivaroxaban | 1 | 2024 | 267 | 0.170 |
Why?
| | Fibrosis | 1 | 2024 | 548 | 0.170 |
Why?
| | Preoperative Care | 1 | 2024 | 379 | 0.170 |
Why?
| | Nurses | 1 | 2024 | 178 | 0.170 |
Why?
| | Patient Readmission | 2 | 2024 | 758 | 0.170 |
Why?
| | Periodicals as Topic | 1 | 2023 | 203 | 0.170 |
Why?
| | Mobile Applications | 1 | 2024 | 196 | 0.170 |
Why?
| | Cost-Benefit Analysis | 1 | 2024 | 634 | 0.170 |
Why?
| | Blood Transfusion | 1 | 2024 | 405 | 0.160 |
Why?
| | Bariatric Surgery | 1 | 2024 | 242 | 0.160 |
Why?
| | Social Media | 1 | 2023 | 171 | 0.160 |
Why?
| | Marijuana Smoking | 1 | 2023 | 250 | 0.160 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 732 | 0.150 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 439 | 0.150 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 497 | 0.140 |
Why?
| | Software | 1 | 2023 | 690 | 0.140 |
Why?
| | Tendinopathy | 1 | 2018 | 32 | 0.140 |
Why?
| | Biomedical Research | 1 | 2024 | 710 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2023 | 767 | 0.130 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 885 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 6048 | 0.120 |
Why?
| | Health Services Accessibility | 1 | 2025 | 1098 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 2 | 2024 | 2730 | 0.120 |
Why?
| | Cannabis | 1 | 2024 | 509 | 0.120 |
Why?
| | Practice Guidelines as Topic | 1 | 2024 | 1560 | 0.120 |
Why?
| | Opioid-Related Disorders | 1 | 2023 | 600 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1795 | 0.110 |
Why?
| | Arthritis, Rheumatoid | 1 | 2024 | 1169 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 1143 | 0.110 |
Why?
| | Cohort Studies | 2 | 2023 | 5960 | 0.110 |
Why?
| | Rupture | 2 | 2025 | 91 | 0.110 |
Why?
| | Prospective Studies | 2 | 2024 | 7990 | 0.110 |
Why?
| | Homeostasis | 1 | 2018 | 640 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1098 | 0.100 |
Why?
| | Obesity | 2 | 2024 | 3077 | 0.100 |
Why?
| | Median Nerve | 2 | 2023 | 27 | 0.100 |
Why?
| | Blood Glucose | 1 | 2024 | 2327 | 0.100 |
Why?
| | Femur Head | 2 | 2023 | 39 | 0.100 |
Why?
| | Hip Joint | 2 | 2025 | 172 | 0.100 |
Why?
| | Tibia | 2 | 2023 | 176 | 0.090 |
Why?
| | Cell Differentiation | 1 | 2018 | 2050 | 0.080 |
Why?
| | Heart Failure | 1 | 2023 | 2323 | 0.070 |
Why?
| | Child | 2 | 2025 | 22633 | 0.070 |
Why?
| | Teriparatide | 1 | 2026 | 10 | 0.060 |
Why?
| | Denosumab | 1 | 2026 | 10 | 0.060 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2026 | 36 | 0.060 |
Why?
| | Diphosphonates | 1 | 2026 | 68 | 0.060 |
Why?
| | Magnetics | 1 | 2025 | 48 | 0.060 |
Why?
| | Ontario | 1 | 2024 | 96 | 0.050 |
Why?
| | Cementation | 1 | 2024 | 5 | 0.050 |
Why?
| | External Fixators | 1 | 2024 | 21 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2025 | 5408 | 0.050 |
Why?
| | Fractures, Malunited | 1 | 2023 | 12 | 0.050 |
Why?
| | Fractures, Ununited | 1 | 2023 | 27 | 0.050 |
Why?
| | Preoperative Period | 1 | 2024 | 149 | 0.050 |
Why?
| | Wrist Joint | 1 | 2024 | 71 | 0.050 |
Why?
| | Open Fracture Reduction | 1 | 2023 | 30 | 0.050 |
Why?
| | Information Systems | 1 | 2023 | 57 | 0.050 |
Why?
| | Printing, Three-Dimensional | 1 | 2024 | 96 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2024 | 276 | 0.050 |
Why?
| | Graft Survival | 1 | 2025 | 526 | 0.050 |
Why?
| | Survivorship | 1 | 2023 | 54 | 0.050 |
Why?
| | Injections | 1 | 2023 | 196 | 0.050 |
Why?
| | Radius Fractures | 1 | 2023 | 69 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2025 | 965 | 0.050 |
Why?
| | Bone Marrow Transplantation | 1 | 2023 | 294 | 0.050 |
Why?
| | Minimal Clinically Important Difference | 1 | 2022 | 30 | 0.050 |
Why?
| | Ceruloplasmin | 1 | 2001 | 9 | 0.040 |
Why?
| | Orosomucoid | 1 | 2001 | 9 | 0.040 |
Why?
| | Postoperative Care | 1 | 2024 | 288 | 0.040 |
Why?
| | Public Opinion | 1 | 2021 | 60 | 0.040 |
Why?
| | Serum Albumin | 1 | 2001 | 147 | 0.040 |
Why?
| | Hepatitis C | 1 | 2023 | 254 | 0.040 |
Why?
| | Endoscopy | 1 | 2023 | 316 | 0.040 |
Why?
| | Operating Rooms | 1 | 2022 | 146 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2024 | 377 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2024 | 583 | 0.040 |
Why?
| | Health Care Costs | 1 | 2023 | 427 | 0.040 |
Why?
| | Obesity, Morbid | 1 | 2023 | 281 | 0.040 |
Why?
| | Biopsy | 1 | 2023 | 1075 | 0.040 |
Why?
| | Recovery of Function | 1 | 2024 | 707 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 730 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2023 | 691 | 0.030 |
Why?
| | Chronic Disease | 1 | 2024 | 1813 | 0.030 |
Why?
| | Mental Health | 1 | 2024 | 790 | 0.030 |
Why?
| | Renal Dialysis | 1 | 2001 | 462 | 0.030 |
Why?
| | Sex Factors | 1 | 2023 | 2112 | 0.030 |
Why?
| | Anxiety | 1 | 2024 | 1109 | 0.030 |
Why?
| | Stem Cells | 1 | 2021 | 626 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 947 | 0.030 |
Why?
| | Animals | 1 | 2018 | 38058 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2023 | 3409 | 0.030 |
Why?
| | Depression | 1 | 2024 | 1558 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1907 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5868 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2310 | 0.020 |
Why?
| | HIV Infections | 1 | 2024 | 3154 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2001 | 167 | 0.010 |
Why?
| | Models, Biological | 1 | 2001 | 1821 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2001 | 2947 | 0.010 |
Why?
|
|
Dubin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|